101 related articles for article (PubMed ID: 10701777)
1. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB.
Li Y; Tharappel JC; Cooper S; Glenn M; Glauert HP; Spear BT
DNA Cell Biol; 2000 Feb; 19(2):113-20. PubMed ID: 10701777
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
Yeldandi AV; Rao MS; Reddy JK
Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
[TBL] [Abstract][Full Text] [Related]
3. Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
Li Y; Glauert HP; Spear BT
Biochem Pharmacol; 2000 Feb; 59(4):427-34. PubMed ID: 10644051
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Spear BT; Glauert HP
Toxicol Appl Pharmacol; 2004 Aug; 199(1):1-9. PubMed ID: 15289085
[TBL] [Abstract][Full Text] [Related]
5. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate.
Tharappel JC; Cunningham ML; Spear BT; Glauert HP
Toxicol Sci; 2001 Jul; 62(1):20-7. PubMed ID: 11399789
[TBL] [Abstract][Full Text] [Related]
7. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
Lee MJ; Gee P; Beard SE
Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
[TBL] [Abstract][Full Text] [Related]
8. Activation of hepatic NF-kappaB by the herbicide Dicamba (2-methoxy-3,6-dichlorobenzoic acid) in female and male rats.
Espandiari P; Ludewig G; Glauert HP; Robertson LW
J Biochem Mol Toxicol; 1998; 12(6):339-44. PubMed ID: 9736482
[TBL] [Abstract][Full Text] [Related]
9. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
[TBL] [Abstract][Full Text] [Related]
10. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
[TBL] [Abstract][Full Text] [Related]
13. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
14. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E inhibits hepatic NF-kappaB activation in rats administered the hepatic tumor promoter, phenobarbital.
Calfee-Mason KG; Spear BT; Glauert HP
J Nutr; 2002 Oct; 132(10):3178-85. PubMed ID: 12368415
[TBL] [Abstract][Full Text] [Related]
17. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity.
Nilakantan V; Spear BT; Glauert HP
Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
19. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice.
Budroe JD; Umemura T; Angeloff K; Williams GM
Toxicol Appl Pharmacol; 1992 Apr; 113(2):192-8. PubMed ID: 1561628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
